AdvisorShares Trust has announced the filing of a summary prospectus for its Dorsey Wright ADR ETF, effective November 1, 2026. This filing is crucial as it outlines the fund's investment objectives, strategies, and fee structure, which are essential for potential investors looking to make informed decisions.
As an investment management company, AdvisorShares Trust focuses on providing innovative investment solutions. The firm is known for its active management approach to exchange-traded funds (ETFs), which allows investors to gain exposure to various asset classes while leveraging professional management.
The recent filing, identified by accession number 0001829126-26-011801, details that the AdvisorShares Dorsey Wright ADR ETF aims for long-term capital appreciation above international benchmarks, such as the MSCI EAFE Index. The fund will invest primarily in American Depositary Receipts (ADRs) and other securities with similar economic characteristics, providing a diversified approach to international investing.
In the filing, the company states, "The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index." This highlights the fund's commitment to outperforming traditional benchmarks, which could attract investors seeking growth in international markets.
The filing also addresses the fund's fees and expenses, noting that the total annual operating expenses are capped at 1.10%. This includes management fees of 0.75% and other expenses, which are critical for investors to consider when evaluating potential returns. The Advisor has contractually agreed to waive fees to maintain this expense ratio for at least one year from the date of the prospectus.
The introduction of the Dorsey Wright ADR ETF may impact various stakeholders, including investors seeking diversified international exposure and competitors in the ETF market. As more investors look for innovative investment solutions, other firms may need to enhance their offerings to remain competitive.
Looking ahead, the filing does not specify what actions will follow this announcement, but it sets the stage for potential investor interest and market response. As the ETF landscape continues to evolve, AdvisorShares Trust's new product may influence investment strategies across the industry.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






